Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2125943 | European Journal of Cancer | 2007 | 8 Pages |
Abstract
Women who remain premenopausal after 6 or 7 cycles of CMF-based chemotherapy have a higher likelihood of going through menopause at an earlier age than women who received little or no chemotherapy. Temporary cessation of menses appears to be a marker for earlier onset of menopause. These findings may assist women and clinicians when making treatment and reproductive decisions after a diagnosis of breast cancer.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ann Partridge, Shari Gelber, Richard D. Gelber, Monica Castiglione-Gertsch, Aron Goldhirsch, Eric Winer,